Literature DB >> 33120003

The influence of post-diuretic late phase imaging in visual and quantitative evaluation of urothelial tumors by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.

Zehra Pınar Koç1, Pelin Özcan Kara1, Emel Sezer2, Kadir Eser2.   

Abstract

OBJECTIVE: Although F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is a valuable imaging method in most of the malignant tumors, it is considered to have limited diagnostic ability in urothelial tumors due to high physiologic urine activity. The aim of the present study was to evaluate the effect of post-diuretic late phase imaging to the visual and quantitative evaluation of urothelial tumors in the staging and restaging of the patients.
MATERIAL AND METHODS: Two patients with ureter and 40 patients with bladder tumors (6 females and 36 males, mean age: 67.12±8.79 years) who were referred for staging or restaging or treatment response evaluation to the F-18 FDG PET/CT were included in the study. Late phase (at the second hour after FDG injection) images including the renal pelvis and bladder region after the administration of approximately 40 mg furosemide were obtained after standard oncologic F-18 FDG PET/CT imaging. The images were evaluated by visual and quantitative interpretation, and index values were calculated. Paired samples T test was used to decide the significance of the difference between the early and late phase images. A p value <0.05 was considered significant.
RESULTS: The activity accumulation in the primary or recurrent lesions in the bladder or ureter in the early and late phase images was statistically significantly different. Additionally, in 15/41 (37%) patients, the primary tumor in the bladder was only determined in late phase images, and additional lymph node metastases adjacent to the bladder or ureter were only observed in diuretic late phase images in some of the patients. The sensitivity, specificity, and diagnostic accuracy of the PET/CT with this methodology for N staging and M staging were 67%, 78%, and 82% versus 80%, 91%, and 82%, respectively.
CONCLUSION: Late phase imaging after diuretic administration should be performed in case of non-visualization of primary tumor in the bladder region. The late phase post-diuretic imaging revealed significant improvement in the visual and quantitative diagnostic performance of the FDG PET/CT and has high diagnostic accuracy for the staging of urothelial tumors.

Entities:  

Year:  2019        PMID: 33120003      PMCID: PMC7595022          DOI: 10.5152/tud.2019.27482

Source DB:  PubMed          Journal:  Turk J Urol        ISSN: 2149-3235


  24 in total

1.  Proposal of a new acquisition protocol for bladder cancer visualization with 18F-FDG PET/CT.

Authors:  Sotirios Chondrogiannis; Maria Cristina Marzola; Patrick M Colletti; Domenico Rubello
Journal:  Clin Nucl Med       Date:  2015-01       Impact factor: 7.794

2.  The effect of furosemide dose timing on bladder activity in oncology imaging with 18F-fluorodeoxyglucose PET/CT.

Authors:  Sundeep Nijjar; Judy Patterson; Jaylene Ducharme; William D Leslie; Sandor J Demeter
Journal:  Nucl Med Commun       Date:  2010-02       Impact factor: 1.690

3.  Prospective Pilot Study to Evaluate the Incremental Value of PET Information in Patients With Bladder Cancer Undergoing 18F-FDG Simultaneous PET/MRI.

Authors:  Andrew B Rosenkrantz; Kent P Friedman; Fabio Ponzo; Roy A Raad; Kimberly Jackson; William C Huang; Arjun V Balar
Journal:  Clin Nucl Med       Date:  2017-01       Impact factor: 7.794

Review 4.  Positron emission tomography for prostate, bladder, and renal cancer.

Authors:  Heiko Schöder; Steven M Larson
Journal:  Semin Nucl Med       Date:  2004-10       Impact factor: 4.446

Review 5.  Clinical value of FDG PET or PET/CT in urinary bladder cancer: a systemic review and meta-analysis.

Authors:  Yu-Yu Lu; Jin-Hua Chen; Ji-An Liang; Hsin-Yi Wang; Cheng-Chieh Lin; Wan-Yu Lin; Chia-Hung Kao
Journal:  Eur J Radiol       Date:  2011-09-06       Impact factor: 3.528

6.  Forced diuresis and dual-phase F-fluorodeoxyglucose-PET/CT scan for restaging of urinary bladder cancers.

Authors:  S Harkirat; Ss Anand; Mj Jacob
Journal:  Indian J Radiol Imaging       Date:  2010-02

Review 7.  Bladder cancer: state-of-the-art care.

Authors:  M J Droller
Journal:  CA Cancer J Clin       Date:  1998 Sep-Oct       Impact factor: 508.702

8.  Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique.

Authors:  Brusabhanu Nayak; Prem Nath Dogra; Niraj Naswa; Rakesh Kumar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-24       Impact factor: 9.236

9.  Can patient selection for bladder preservation be based on response to chemotherapy?

Authors:  Cora N Sternberg; Vito Pansadoro; Fabio Calabrò; Sylvia Schnetzer; Diana Giannarelli; Paolo Emiliozzi; Francesco De Paula; Paolo Scarpone; Piero De Carli; Maurizio Pizzo; Andrea Platania; Mostafà Amini
Journal:  Cancer       Date:  2003-04-01       Impact factor: 6.860

Review 10.  Bladder cancer.

Authors:  Donald S Kaufman; William U Shipley; Adam S Feldman
Journal:  Lancet       Date:  2009-06-10       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.